EuSepScreen Lattanti (8 tests)
- Risk class
- III
- Product type
- In Vitro Diagnostic
- Brand name
- Eurospital
- Commercial name
- 19-238 IVD Reagents/Kits, Molecular Assay, Infection, Bacteria
- Analysis ID
- c1567fa3761740aacd971f1a576790c8
- Registration date
- April 05, 2023
- Expiration date
- April 05, 2028
- Name
- EUROSPITAL SPA
- City
- TRIESTE
- Country
- ITALY
- Address
- VIA FLAVIA, 122, 34147 TRIESTE, ITALY
- Name
- EUROSPITAL SPA
- Country
- ITALY
- Address
- AV. EUGENIO ESPEJO 2410 VIA A TANDA NAYON, PLAZA DEL RANCHO
- Phone
- 987070898
THE EUSEPSCREEN LATTANTI KIT IS USED BY REAL-TIME PCR AMPLIFICATION, TO DETERMINE THE PRESENCE OF ANY BATTERY DNA BELONGING TO ALL SEROTYPES OF KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, STREPTOCOCCUS AGALACTIAE (STREPTOCOCCUS B OR GBS) AND LISTERIA MONOCYTOGENES IN BIOLOGICAL SAMPLES, SUCH AS BLOOD, CEREBROSPINAL FLUID, PLEURAL AND SYNOVIAL FLUID, OR ANY OTHER HUMAN MATERIAL OR NORMALLY STERILE BIOLOGICAL MATERIAL.
Access comprehensive regulatory information for EuSepScreen Lattanti (8 tests) in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID c1567fa3761740aacd971f1a576790c8 and manufactured by EUROSPITAL SPA. The device was registered on April 05, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.